healthcare
healthcare Articles
Alexion Pharmaceutical shares shot up on Monday after it was announced over the weekend that the company would be acquired by AstraZeneca.
Published:
CureVac advanced in the fight against COVID-19 by beginning enrollment in its midstage vaccine candidate study. As a result, investors cheered on this news and sent shares higher.
Published:
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Published:
Curis shares are on the run again. This time it’s due to a secondary offering.
Published:
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Published:
After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
Published:
Sutro Biopharma made a huge gain to close out the week after the firm provided an update from its ongoing dose-escalation in its ovarian cancer trial.
Published:
Health care has been a top performer this year, and there is every reason to believe that performance will carry through into 2021. These are four of the highest-ranked health care ideas from the...
Published:
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
Published:
Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.
Published:
Large marijuana stocks have risen sharply since the U.S. elections early in November. The increase is not based so much on the results as on what could happen next.
Published:
Moderna shares continued to run higher on Monday after the company announced an update for the primary efficacy analysis for its late-stage coronavirus vaccine trial.
Published:
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Published: